Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
- Conditions
- MonocytesMultiple MyelomaCART Cells
- Registration Number
- NCT07180992
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Tumoral micro-environment in malignant haematological diseases, notably in multiple myeloma, is active on plasma cells survival and proliferation. Monocytosis and monocytes typing are described in multiple myeloma response as factors on proliferation and cell death evasion. CART cells have improved multiple myeloma care in last 5 years, nethertheless, early relapse occur and we must identify predictor factors of better response. The aim of this study is to analyze basic level and phenotyping of monocytes before and after CART cells infusion and study their impact on multiple myeloma response
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 25
- Patients over 18 years old
- Treated for a multiple myeloma
- CART cells treatment proposed
- Affiliated to social security system
- Agreed to participate to the study
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall response rate day 1
- Secondary Outcome Measures
Name Time Method Progression free survival 3 years Overall survival 3 years time to next treatment 3 years
Trial Locations
- Locations (1)
CHRU Amiens
🇫🇷Amiens, France
CHRU Amiens🇫🇷Amiens, FranceLydia Montes, MDContact33+322088371Montes.lydia@chu-amiens.fr
